Yehl, M.; Kucharski, D.; Eubank, M.; Gulledge, B.; Rayan, G.; Uddin, M.G.; Remmers, G.; Kandel, E.S.; DuFaux, D.P.; Hutcherson, T.C.;
et al. The Development of Nonthermal Plasma and Tirapazamine as a Novel Combination Therapy to Treat Melanoma In Situ. Cells 2023, 12, 2113.
https://doi.org/10.3390/cells12162113
AMA Style
Yehl M, Kucharski D, Eubank M, Gulledge B, Rayan G, Uddin MG, Remmers G, Kandel ES, DuFaux DP, Hutcherson TC,
et al. The Development of Nonthermal Plasma and Tirapazamine as a Novel Combination Therapy to Treat Melanoma In Situ. Cells. 2023; 12(16):2113.
https://doi.org/10.3390/cells12162113
Chicago/Turabian Style
Yehl, Matthew, Dominik Kucharski, Michelle Eubank, Brandon Gulledge, Gamal Rayan, Md Gias Uddin, Genevieve Remmers, Eugene S. Kandel, Douglas P. DuFaux, Timothy C. Hutcherson,
and et al. 2023. "The Development of Nonthermal Plasma and Tirapazamine as a Novel Combination Therapy to Treat Melanoma In Situ" Cells 12, no. 16: 2113.
https://doi.org/10.3390/cells12162113
APA Style
Yehl, M., Kucharski, D., Eubank, M., Gulledge, B., Rayan, G., Uddin, M. G., Remmers, G., Kandel, E. S., DuFaux, D. P., Hutcherson, T. C., Sexton, S., & Zucker, S. N.
(2023). The Development of Nonthermal Plasma and Tirapazamine as a Novel Combination Therapy to Treat Melanoma In Situ. Cells, 12(16), 2113.
https://doi.org/10.3390/cells12162113
